Cholangiocarcinoma
Showing NaN - NaN of 9
Cholangiocarcinoma Trial in Worldwide (Tinengotinib 8 mg, Tinengotinib 10 mg, Physician's Choice)
Not yet recruiting
- Cholangiocarcinoma
- Tinengotinib 8 mg
- +2 more
-
Santa Monica, California
- +13 more
Jul 7, 2023
Multi-Platform Profiling of Resected Biliary Tract Cancer
Recruiting
- Biliary Tract Cancer
- +7 more
- Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
-
Chicago, Illinois
- +1 more
Jan 23, 2023
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)
Active, not recruiting
- Cholangiocarcinoma
- Fimaporfin and Gemcitabine
- Gemcitabine/Cisplatin chemotherapy
-
Duarte, California
- +49 more
Mar 4, 2022
Cholangiocarcinoma, Hilar Lymphadenopathy, Biliary Stricture Trial in United States (PTBD, ERC)
Terminated
- Cholangiocarcinoma
- +2 more
- PTBD
- ERC
-
Los Angeles, California
- +24 more
Mar 23, 2020
Cholangiocarcinoma Trial in Austria, United States (Nab-Paclitaxel and Gemcitabine)
Completed
- Cholangiocarcinoma
- Nab-Paclitaxel and Gemcitabine
-
Denver, Colorado
- +24 more
Sep 5, 2018